XII Jornada Mineira de Radiologia
Acesse o site do congresso
1º Dia - 6/19/26
2º Dia - 6/20/26

Amiloide e Tau PET: quando usar e quando evitar nos fluxos de cuidado cognitivo Voltar

Cristina Matushita

Curso: Medicina Nuclear - Sessão 2 - Neurologia - Cintilografia de perfusão cerebral: ainda há espaço no cenário do avanço dos marcadores PET?

Artigo Autor(es) Referência
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. Rabinovici Gil D, Gatsonis Constantine, Apgar Charles, Chaudhary Kiran, Gareen Ilana, Hanna Lucy, Hendrix James, Hillner Bruce E, Olson Cynthia, Lesman-Segev Orit H, Romanoff Justin, Siegel Barry A, Whitmer Rachel A, Carrillo Maria C JAMA. 2019 Apr; 321(Apr):1286-1294. doi: 10.1001/jama.2019.2000. pii: .
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Leuzy Antoine, Bollack Ariane, Pellegrino Daniela, Teunissen Charlotte E, La Joie Renaud, Rabinovici Gil D, Franzmeier Nicolai, Johnson Keith, Barkhof Frederik, Shaw Leslie M, Arkhipenko Alexander, Schindler Suzanne E, Honig Lawrence S, Moscoso Rial Alexis, Schöll Michael, Zetterberg Henrik, Blennow Kaj, Hansson Oskar, Farrar Gill Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025 Mar; 21(Mar):e14528. doi: 10.1002/alz.14528. pii: e14528.
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy Antoine, Smith Ruben, Ossenkoppele Rik, Santillo Alexander, Borroni Edilio, Klein Gregory, Ohlsson Tomas, Jögi Jonas, Palmqvist Sebastian, Mattsson-Carlgren Niklas, Strandberg Olof, Stomrud Erik, Hansson Oskar JAMA neurology. 2020 Aug; 77(Aug):955-965. doi: 10.1001/jamaneurol.2020.0989. pii: .
Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls. Burkett Brian J, Johnson Derek R, Lowe Val J Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024 Jun; 65(Jun):829-837. doi: 10.2967/jnumed.123.266463. pii: .
Guidelines for the use and interpretation of Alzheimer's disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Studart-Neto Adalberto, Barbosa Breno José Alencar Pires, Coutinho Artur Martins, de Souza Leonardo Cruz, Schilling Lucas Porcello, da Silva Mari Nilva Maia, Castilhos Raphael Machado, Bertolucci Paulo Henrique Ferreira, Borelli Wyllians Vendramini, Gomes Hélio Rodrigues, Fernandes Gustavo Bruniera Peres, Barbosa Maira Tonidandel, Balthazar Marcio Luiz Figueredo, Frota Norberto Anízio Ferreira, Forlenza Orestes Vicente, Smid Jerusa, Brucki Sonia Maria Dozzi, Caramelli Paulo, Nitrini Ricardo, Engelhardt Eliasz, Resende Elisa de Paula França Dementia & neuropsychologia. 2024 ; 18():e2024C001. doi: 10.1590/1980-5764-DN-2024-C001. pii: e2024C001.
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients. Matsuda Hiroshi, Hanyu Haruo, Kaneko Chikako, Ogura Masato, Yamao Tensho Annals of nuclear medicine. 2025 May; 39(May):458-465. doi: 10.1007/s12149-025-02018-7. pii: .
Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease Matthias Brendel a b c d e ⁎ , Phillip H. Kuo f , Joachim Brumberg g h , Vincent Doré i j , Alexander Drzezga k l m , Valentina Garibotto n o p , Antoine Leuzy q , Gregory Mathoux n , Philipp T. Meyer g h , Alexis Moscoso q r , Rik Ossenkoppele s t , Tharick Pascoal u v , Ruben Smith s w , John Seibyl x , Elsmarieke van de Giessen y , Donatienne Van Weehaeghe z , Marie R. Vermeiren aa , Victor L. Villemagne j u ab , Shadi A. Esfahani ac ad , Henryk Barthel ae af … Igor Yakushev BRENDEL, M. et al. Joint EANM/SNMMI Recommendations on the Use of Tau PET Imaging in Alzheimer’s Disease. The EANM Journal, p. 100214, mar. 2026. ‌
Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer's Disease. Gogola Alexandra, Lopresti Brian J, Minhas Davneet S, Lopez Oscar, Cohen Ann, Villemagne Victor L Geriatrics (Basel, Switzerland). 2025 Feb; 10(Feb):doi: 10.3390/geriatrics10010027. pii: 27.
The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review. Nasrallah Ilya M, Kuo Phillip H, Nordberg Agneta, Bohnen Nicolaas I, Ponisio Maria R AJR. American journal of roentgenology. 2025 Nov; 225(Nov):e2432325. doi: 10.2214/AJR.24.32325. pii: .
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. Chapleau Marianne, Iaccarino Leonardo, Soleimani-Meigooni David, Rabinovici Gil D Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2022 Jun; 63(Jun):13S-19S. doi: 10.2967/jnumed.121.263195. pii: .
The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer's Disease-Review of Literature and Interesting Images. Suppiah Subapriya, Didier Mellanie-Anne, Vinjamuri Sobhan Diagnostics (Basel, Switzerland). 2019 Jun; 9(Jun):doi: 10.3390/diagnostics9020065. pii: E65.
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Rabinovici Gil D, Knopman David S, Arbizu Javier, Benzinger Tammie L S, Donohoe Kevin J, Hansson Oskar, Herscovitch Peter, Kuo Phillip H, Lingler Jennifer H, Minoshima Satoshi, Murray Melissa E, Price Julie C, Salloway Stephen P, Weber Christopher J, Carrillo Maria C, Johnson Keith A Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025 Jan; 21(Jan):e14338. doi: 10.1002/alz.14338. pii: e14338.
Nenhuma revista foi definida para este congresso.